US · Healthcare · Medical Devices
EPS came in at -1.46 against a street estimate of -3.00 — a beat of 51.3%.
Analysts rate Co-Diagnostics, Inc. Common Stock a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $4.00.
| Fund | Stake |
|---|---|
| Armistice Capital, LLC | 3.38% |
| Jane Street Group LLC | 1.28% |
| Vanguard Capital Management, LLC | 0.83% |
| Private Asset Group LLC | 0.56% |
| Millennium Management LLC | 0.46% |
| Susquehanna International Group, LLP | 0.45% |
| Geode Capital Management, LLC | 0.37% |
| Vanguard Fiduciary Trust Co | 0.28% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Co-Diagnostics, Inc. Common Stock — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-18.